Atlas Trials

Parkinson Disease Psychosis

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Parkinson Disease Psychosis

RecordFirmDate
A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis (NCT05344365)Vanda Pharmaceuticals2022-06-01
Presence Hallucination in Parkinson's Disease (NCT04579887)Olaf Blanke2020-08-17
Hallucinations in Parkinson's Disease (NCT04592965)Olaf Blanke2020-08-17
Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis (NCT04292223)ACADIA Pharmaceuticals Inc.2020-02-10
Characterization and Progression of Minor Phenomena in Parkinson's Disease (PD) (NCT05240339)University of Rochester2019-04-25
SRC Inhibition as a Potential Target for Parkinson's Disease Psychosis (NCT03661125)King's College London2019-04-11
The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study (NCT03152292)ACADIA Pharmaceuticals Inc.2017-03-30
A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis (NCT02969369)Otsuka Pharmaceutical Development & Commercialization, Inc.2016-12-31

Track Parkinson Disease Psychosis automatically

Every clearance here is in the API, with alerts when new ones post.